论文部分内容阅读
目的 :利用羟基磷灰石 (hydroxyapatite ,HA)眼台作为药物载体缓慢释放于眼窝后以减轻HA眼台眼窝内填充术后疼痛及术后反应。方法 :眼窝内植入义眼台后于眼台内注入醋酸地塞米松 5mg(1ml) ,盐酸妥布霉素 4万U(2ml)。余步骤同经典步骤。结果 :4 4例患者中 4 3例 (98% )无痛感或仅有轻微疼痛。 2 9例患者 (6 6 % )有不同程度的恶心 ,17例 (39% )还伴有呕吐。 80 %患者没有出现组织水肿。结论 :义眼台内注入地塞米松及妥布霉素能有效地控制术后疼痛 ,减轻术后反应 ,明显地减轻患者痛苦
OBJECTIVE: To use hydroxyapatite (HA) ophthalmic as a drug carrier to slowly release into the orbital to relieve pain and postoperative response of HA eye socket. METHODS: Dexamethasone acetate 5 mg (1 ml) and tobramycin hydrochloride 40,000 U (2 ml) were injected into the orbital cavity after implantation of the eye socket. More steps with the classic steps. Results: Of the 4 4 patients, 43 (98%) had no pain or only slight pain. There were 29 patients (66%) with varying degrees of nausea and 17 (39%) with vomiting. 80% of patients did not appear tissue edema. CONCLUSION: Dexamethasone and tobramycin can effectively control the postoperative pain, reduce the postoperative reaction and relieve the patient’s pain obviously